Cipla gains 2% on zero observations for Indore facility

The share touched its 52-week high Rs 678 and 52-week low Rs 483.75 on 19 September 2018 and 29 January 2019, respectively.

Share price of Cipla gained 2.5 percent in the early trade on Monday after USFDA issued zero observations for its Indore facility.


United States Food and Drug Administration (USFDA) conducted a post-approval inspection at the company's Indore facility from May 13 to May 17, 2019, and the said inspection ended with zero observations.

At 09:42 hrs Cipla was quoting at Rs 555.10, up to Rs 11.15, or 2.05 percent on the BSE.

The share touched its 52-week high Rs 678 and 52-week low Rs 483.75 on 19 September 2018 and 29 January 2019, respectively.

Currently, it is trading 18.13 percent below its 52-week high and 14.74 percent above its 52-week low.

Currently, it is trading 18.13 percent below its 52-week high and 14.74 percent above its 52-week low.

Get a 2 days free trial in Stock Market Tips and MCX Tips  

Comments

Popular posts from this blog

Technical Classroom: How to use Fibonacci Retracement Levels in stock trading

Veto Switchgears jumps 5% on realisation of unsecured loan

Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term